These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 26183437)

  • 1. A comparison of measures used to describe adherence to glaucoma medication in a randomised controlled trial.
    Cate H; Bhattacharya D; Clark A; Holland R; Broadway DC
    Clin Trials; 2015 Dec; 12(6):608-17. PubMed ID: 26183437
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adherence improvement in Dutch glaucoma patients: a randomized controlled trial.
    Beckers HJ; Webers CA; Busch MJ; Brink HM; Colen TP; Schouten JS;
    Acta Ophthalmol; 2013 Nov; 91(7):610-8. PubMed ID: 23025424
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improving adherence to glaucoma medication: a randomised controlled trial of a patient-centred intervention (The Norwich Adherence Glaucoma Study).
    Cate H; Bhattacharya D; Clark A; Fordham R; Holland R; Broadway DC
    BMC Ophthalmol; 2014 Mar; 14():32. PubMed ID: 24655814
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adherence with topical glaucoma medication monitored electronically the Travatan Dosing Aid study.
    Okeke CO; Quigley HA; Jampel HD; Ying GS; Plyler RJ; Jiang Y; Friedman DS
    Ophthalmology; 2009 Feb; 116(2):191-9. PubMed ID: 19084273
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patterns of adherence behaviour for patients with glaucoma.
    Cate H; Bhattacharya D; Clark A; Holland R; Broadway DC
    Eye (Lond); 2013 Apr; 27(4):545-53. PubMed ID: 23328800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protocol for a randomised controlled trial to estimate the effects and costs of a patient centred educational intervention in glaucoma management.
    Cate H; Bhattacharya D; Clark A; Fordham R; Notley C; Broadway DC
    BMC Ophthalmol; 2012 Nov; 12():57. PubMed ID: 23171166
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patterns and rate of adherence to glaucoma therapy using an electronic dosing aid.
    Ajit RR; Fenerty CH; Henson DB
    Eye (Lond); 2010 Aug; 24(8):1338-43. PubMed ID: 20339390
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparisons of Self-reported Glaucoma Medication Adherence With a New Wireless Device: A Pilot Study.
    Gatwood JD; Johnson J; Jerkins B
    J Glaucoma; 2017 Nov; 26(11):1056-1061. PubMed ID: 29099436
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Electronic monitoring to assess adherence with once-daily glaucoma medications and risk factors for nonadherence: the automated dosing reminder study.
    Boland MV; Chang DS; Frazier T; Plyler R; Friedman DS
    JAMA Ophthalmol; 2014 Jul; 132(7):838-44. PubMed ID: 24830878
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors for poor adherence to eyedrops in electronically monitored patients with glaucoma.
    Friedman DS; Okeke CO; Jampel HD; Ying GS; Plyler RJ; Jiang Y; Quigley HA
    Ophthalmology; 2009 Jun; 116(6):1097-105. PubMed ID: 19376591
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of Medication Adherence Assessment Tools to Identify Glaucoma Medication Nonadherence.
    Cho J; Niziol LM; Lee PP; Heisler M; Resnicow K; Musch DC; Newman-Casey PA
    Ophthalmol Glaucoma; 2022; 5(2):137-145. PubMed ID: 34358735
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determinants of medication adherence to topical glaucoma therapy.
    Dreer LE; Girkin C; Mansberger SL
    J Glaucoma; 2012; 21(4):234-40. PubMed ID: 21623223
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interventions improve poor adherence with once daily glaucoma medications in electronically monitored patients.
    Okeke CO; Quigley HA; Jampel HD; Ying GS; Plyler RJ; Jiang Y; Friedman DS
    Ophthalmology; 2009 Dec; 116(12):2286-93. PubMed ID: 19815286
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The influence of the Travalert(®) dosing aid on medical treatment compliance and the quality of life of glaucoma patients].
    Sánchez-Pulgarín M; Martínez-de-la-Casa JM; Escalada A; Sáenz-Francés F; García-Feijoó J; García Sánchez J
    Arch Soc Esp Oftalmol; 2011 Sep; 86(9):282-6. PubMed ID: 21893261
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ophthalmologist-patient communication, self-efficacy, and glaucoma medication adherence.
    Sleath B; Blalock SJ; Carpenter DM; Sayner R; Muir KW; Slota C; Lawrence SD; Giangiacomo AL; Hartnett ME; Tudor G; Goldsmith JA; Robin AL
    Ophthalmology; 2015 Apr; 122(4):748-54. PubMed ID: 25542521
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Study on Incentives for Glaucoma Medication Adherence (SIGMA): study protocol for a randomized controlled trial to increase glaucoma medication adherence using value pricing.
    Bilger M; Wong TT; Howard KL; Lee JY; Toh AN; John G; Lamoureux EL; Finkelstein EA
    Trials; 2016 Jul; 17(1):316. PubMed ID: 27422389
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Most Common Barriers to Glaucoma Medication Adherence: A Cross-Sectional Survey.
    Newman-Casey PA; Robin AL; Blachley T; Farris K; Heisler M; Resnicow K; Lee PP
    Ophthalmology; 2015 Jul; 122(7):1308-16. PubMed ID: 25912144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of parental health literacy and dosing responsibility on pediatric glaucoma medication adherence.
    Freedman RB; Jones SK; Lin A; Robin AL; Muir KW
    Arch Ophthalmol; 2012 Mar; 130(3):306-11. PubMed ID: 22411659
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Feasibility, Patient Acceptability, and Preliminary Efficacy of a Culturally Informed, Health Promotion Program to Improve Glaucoma Medication Adherence Among African Americans: "Glaucoma Management Optimism for African Americans Living with Glaucoma" (GOAL).
    Dreer LE; Owsley C; Campbell L; Gao L; Wood A; Girkin CA
    Curr Eye Res; 2016; 41(1):50-8. PubMed ID: 25625187
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The relationship between glaucoma medication adherence, eye drop technique, and visual field defect severity.
    Sleath B; Blalock S; Covert D; Stone JL; Skinner AC; Muir K; Robin AL
    Ophthalmology; 2011 Dec; 118(12):2398-402. PubMed ID: 21856009
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.